# VUGENE

> Just another Astra Starter Templates site


## Posts

- [From the Laboratory to the Frontline: What is Missing for Biotech to Integrate into the Defense Sector?](https://vugene.com/from-the-laboratory-to-the-frontline/): The biotechnology sector views itself as a potential defense partner, already offering solutions applicable on the front lines. However, industry representatives note that clearer strategic direction from the state and consistent dialogue with defense institutions are needed to achieve a breakthrough. Gražina Mykolaitytė – Nielsen, CEO of VUGENE, states, “Biotechnology is becoming a strategic pillar of national security. Health, biological resilience, cognitive function, and rapid innovation cycles are becoming just as vital as traditional weaponry – a view NATO is already clearly adopting.” Key areas where biotechnology is critical for defense include antimicrobial resistance in conflict zones, frontline mobile laboratories […]
- [Decoding HIV-Associated Aging: Impact of Host Age and Tissue-Specific Responses](https://vugene.com/decoding-hiv-associated-aging-impact-of-host-age-and-tissue-specific-responses/): While modern antiretroviral therapy (ART) has transformed HIV from a fatal diagnosis into a manageable chronic condition, a critical challenge remains: people living with HIV experience accelerated biological aging and a higher burden of comorbidities. However, is this aging process uniform across all patient ages and tissues? Research from the University of Pittsburgh, in collaboration with our team at VUGENE and the Epigenetic Clock Foundation, utilized a primate HIV model (SIV infection in rhesus macaques) to answer a key question: Does the age at which an individual is infected influence biological aging trajectories? Is this effect uniform, or does it […]
- [VUGENE Partners with Inotiv to Enter Pharmaceutical Services Market](https://vugene.com/multi-omics-analysis-specialist-vugene-enters-pharmaceutical-services-market-with-inotiv-collaboration/): VUGENE is partnering with leading Contract Research Organization (CRO) Inotiv, Inc. (NASDAQ: NOTV) in a new strategic collaboration. The collaboration is designed to accelerate AI-assisted drug discovery and enhance data-driven insights across the drug development continuum. For VUGENE it represents an important entry into the Pharmaceutical Services market. Through this partnership, Inotiv will integrate VUGENE’s cloud-based bioinformatics and computational platform into its Discovery & Translational Sciences Division, enabling a more efficient and intelligent analysis of complex biological data. The collaboration will enhance Inotiv’s ability to interpret the full spectrum of epigenomic, proteomic, and other molecular datasets, with the goal of […]
- [How VUGENE Analysis Shed Light on the Inflammatory Impacts of Phenolic-Containing Insulin Preservatives in Commercial Insulin Formulations](https://vugene.com/how-vugene-analysis-shed-light-on-the-inflammatory-impacts-of-phenolic-containing-insulin-preservatives-in-commercial-insulin-formulations/): Client Dr. Ulrike Menkes, Wayne State University Background Insulin phenolic preservatives (IPPs) are added to all commercial insulin formulations to ensure insulin stability, extend shelf life, and provide bactericidal properties. However, since they are not native to the body, researchers questioned whether they trigger an immune response when delivered into the skin over an extended period, a reality of daily life for diabetes patients. Dr. Ulrike Menkes of Wayne State University and her research colleagues aimed to investigate this immune response within the context of extending the lifespan of insulin infusion devices.  Standard insulin infusion sets are approved for use […]
- [Transcriptomics](https://vugene.com/transcriptomics/): Transcriptomics (or more specifically RNA-seq) is one of the most dynamic processes in biology where thousands of RNAs are transcribed and degraded every minute. While RNA takes many different forms and functions – messenger, transfer, ribosomal, non-coding, virus genome, etc. – most commonly scientists are interested in the messenger RNA (mRNA). As the abundance and isoforms of mRNA change dynamically based on conditions (e.g., tissue, disease, treatments) and across different timepoints, this can be very informative. Although proteomics or metabolomics are even more dynamic and responsive, transcriptomics remains a well-understood, sequence-based method that already shows the response to dynamic biological […]
- [Can Monitoring of Epigenetic Age Help to Prevent Injuries in Professional Athletes?](https://vugene.com/can-monitoring-of-epigenetic-age-help-to-prevent-injuries-in-professional-athletes/): The emerging field of epigenetic clocks offers a revolutionary way to enhance personalized training and strategic sports management. The core question is: Could these biological age predictors be utilized to serve as biomarkers for enhancing personalized training and sports management? To tackle this, a team at VUGENE, in collaboration with the Epigenetic Clock Development Foundation and other partners, initiated a focused study on professional soccer players. This research specifically tracks the impact of intensive physical activity on DNA methylation age across pre- and post-match intervals throughout the season. The connection between physical activity and epigenetic aging was measured by dynamic […]
- [The Impact of an Experimental Senolytic Drug on Muscle Injury in Young and Old Mice - Multi-omics Insights and Changes in DNA Methylation Age](https://vugene.com/multi-omics-provide-insights-into-changes-in-dna-methylation-age-the-impact-of-an-experimental-senolytic-drug-on-muscle-injury-in-young-and-old-mice/): The presence of senescent cells is commonly viewed as a hallmark of aging, as is an increase in cellular DNA methylation age (DNAmAGE). In a recent study, researchers looked at an experimental drug that removes senescent cells (senolytics) and observed the epigenetic and transcriptomic responses in mice. A team of academic researchers (at the University of Arkansas and others) in collaboration with industrial partners, the Clock Foundation and VUGENE team, examined the effects of this senolytic drug (BI01) on mouse muscle injury (by injection of BaCl2) and regeneration. Previously, this compound was shown to specifically target p53-MDM2 and reduce the […]
- [Epigenomics](https://vugene.com/epigenomics/): Epigenomics is the study of chemical modifications to DNA and histones that influence gene expression without altering the underlying genetic code. These modifications, such as DNA methylation and histone modifications, act as molecular switches, determining which genes are turned on or off in different cells and conditions. Unlike genetic mutations, epigenetic changes are reversible and influenced by multiple factors, including environment, lifestyle, and diseases. Over the past decades, advancements in high-throughput sequencing and single-cell technologies have also revolutionized epigenomic research. Techniques like Nanopore sequencing, whole-genome bisulfite sequencing (WGBS), ATAC-seq, and ChIP-seq provide unprecedented insights into DNA methylation, chromatin accessibility, and […]
- [VUGENE – New Approaches For “Getting Data to Confess”](https://vugene.com/getting-data-to-confess/): Juozas Gordevičius, CTO and Founder of VUGENE   Over recent decades, improved understanding of the omics sciences has been crucial to the development of new treatments and screening methods for disease. So far, genomics has stood out from the crowd, becoming widely accepted as a tool capable of inducing real change. It has already enabled great strides to be made in cancer detection and treatment, thanks to the advent of advanced liquid biopsy technologies, and has significantly improved our ability to treat rare diseases. A recent highlight in the genomics field came in May of this year. A baby boy, […]
- [Epigenetic Insights into Vascular Cognitive Impairment: DNA Methylation in the Human Brain Tissue](https://vugene.com/epigenetic-insights-into-vascular-cognitive-impairment-dna-methylation-in-the-human-brain-tissue/): Exciting new research from our team at VUGENE and our collaborators at Corewell Health and Acibadem University reveals key epigenetic insights into a common but under-recognized cause of dementia: Vascular Cognitive Impairment (VCI). By examining the superior parietal brain region in VCI patients and healthy controls, our team discovered four major insights: A Dominant Pattern of Gene Silencing: We identified 3,601 significantly altered DNA methylation sites, with a remarkable 82% showing increased hypermethylation in the VCI group. Key Genes are Affected: Epigenetic modifications impact crucial genes like MTCH2, DPRX, and DENND4A, which are linked to neuronal health, vascular integrity, and […]
- [Multi-omics](https://vugene.com/multi-omics/): In the era of high-throughput sequencing and advanced molecular profiling, researchers are increasingly turning to multi-omics approaches to achieve a comprehensive view of biological systems. By integrating multiple omics layers—genomics, transcriptomics, proteomics, metabolomics, metagenomics, and more—scientists can uncover complex molecular interactions, identify novel disease biomarkers, and gain deeper insights into molecular pathways and regulatory mechanisms. Omics integration to study complex molecular patterns. However, currently, multi-omics analysis presents challenges, including data heterogeneity, high dimensionality, technical variability, and the demand for robust bioinformatics pipelines. Most importantly, the field highly lacks people with the particular skills and knowledge about various omics analysis and […]
- [Single-Cell Omics](https://vugene.com/single-cell-omics/): Single-cell omics refers to a set of high-resolution approaches that enables the application of various omics technologies on individual cells offering exceptional single-cell resolution. Unlike bulk analyses that average signals across thousands of diverse cells, single-cell approaches capture cellular heterogeneity, enabling deeper insights into complex biological systems. Recent advances in single-cell RNA sequencing (scRNA-seq), single-cell WGBS sequencing (scWGBS-seq), and single-cell proteomics have taken omics research to a whole new level. These cutting-edge tools allow scientists to explore how cells develop, how diseases progress, and how the immune system responds—down to the finest details that were previously impossible to achieve.   […]
- [Genomics](https://vugene.com/genomics/): Genomics is the comprehensive study of an organism’s entire DNA sequence—its genome—including genes, non-coding regions, and their functions. Unlike traditional genetics, which examines individual genes in isolation, genomics takes a holistic approach, analyzing how genes interact with one another and their environment. Genomics has revolutionized our understanding of human health, disease mechanisms, and the genetic diversity of organisms ranging from microbes to plants, animals, and humans. Over the past few decades, rapid advancements in sequencing technologies have transformed genomics research. Techniques such as Next-Generation Sequencing (NGS), Whole-Genome Sequencing (WGS), and single-cell sequencing now allow scientists to analyze genetic variation and […]
- [Lipid Profiling of Parkinson’s Disease Brain Highlights Disruption in Lysophosphatidylcholines and Triacylglycerol Metabolism](https://vugene.com/lipid-profiling-of-parkinsons-disease-brain-highlights-disruption-in-lysophosphatidylcholines-and-triacylglycerol-metabolism/): Today, VUGENE highlights a new study investigating the lipidomic landscape of Parkinson’s disease, revealing significant disruptions in brain lipid metabolism and uncovering potential biomarkers for early detection and therapeutic monitoring. In collaboration with international researchers and our long-term partners at the Corewell Health Institute, VUGENE’s team analyzed postmortem brain tissue from Parkinson’s patients and matched controls using high-resolution targeted lipidomics to uncover detailed molecular changes in lipid composition. Key findings from the study: Major lipid class disruptions: We identified a significant increase in triacylglycerols (TAGs) and a decrease in lysoglycerophosphocholines (LGCs) in Parkinson’s disease brains, reflecting broad alterations in lipid […]
- [Metabolomics](https://vugene.com/metabolomics/): Metabolomics is the large-scale study of small molecules, commonly known as metabolites, within biological samples. These metabolites represent the final downstream products of gene expression and biochemical processes, providing a real-time snapshot of cellular function and capturing the actual physiological state of a system, reflecting changes due to disease, treatments, diet, or environmental factors.   The Advancement of Technology and Popularity    Mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy markedly contributed to the rapid application of metabolomics in research. These powerful tools enable high-throughput and precise profiling of metabolites, making metabolomics an essential part of modern biological and […]
- [Slowed Epigenetic Aging in Olympic Champions Compared to Non-champions](https://vugene.com/slowed-epigenetic-aging-in-olympic-champions-compared-to-non-champions/): VUGENE highlights a study showing that Olympic champions exhibit slower epigenetic aging compared to non-champions, suggesting that years of high-level training and physical discipline may promote healthier biological aging. Researchers analyzed DNA methylation-based epigenetic clocks in Olympic gold medalists and matched controls (non-athletes and non-medalists) to explore how elite athletic performance influences biological age. In the study was identified the top 20 genes that showed the most remarkable difference in promoter methylation between these groups. The hypo-methylated genes are involved in synaptic health, glycosylation, metal ion membrane transfer, and force generation. Most of the hyper-methylated genes were associated with cancer […]
- [Proteomics](https://vugene.com/proteomics/): Proteomics is a large-scale study of proteins, their structures, functions, and interactions within biological systems. By analyzing the proteome—the complete set of proteins expressed by a cell, tissue, or organism—we gain insights into cellular processes, disease mechanisms, and potential therapeutic targets. In recent years, the proteomics landscape has been transformed by technological advances. Techniques like mass spectrometry and liquid chromatography, along with advanced bioinformatics tools, have enabled researchers to investigate proteins at a large scale. These advancements have enabled the identification and quantification of thousands of proteins simultaneously, offering a comprehensive view of cellular function and organization. How Proteomics is […]
- [Epigenetic and Metabolic Landscape of Dementia with Lewy Bodies](https://vugene.com/epigenetic-and-metabolic-landscape-of-dementia-with-lewy-bodies/): VUGENE highlights a study exploring the epigenetic and metabolic landscape of Dementia with Lewy Bodies (DLB), uncovering potential biomarkers and offering new insights into disease mechanisms. VUGENE’s team, together with collaborators, analyzed postmortem brain tissues to integrate epigenetic and metabolic data using integrative multi-omics methods, providing a more comprehensive view of the disease’s pathology. Key insights from the study: Epigenetic alterations: Increased DNA hypermethylation, especially in genes related to synaptic activity and olfactory function, aligning with known DLB symptoms. Metabolic disruptions: Changes in Phosphatidylethanolamine (PE) biosynthesis pathways suggest a link to neurodegeneration. Sex-specific differences: Females exhibited more epigenetic and metabolomic […]
- [VUGENE Secures 1 Million Euros to Revolutionize Biological Research](https://vugene.com/vugene-secures-1-million-euros-to-revolutionize-biological-research/): Financing led by Superhero Capital backed by NGL Ventures, Coinvest Capital and angel investors Building on strong international R&D customer base across biotech, pharma and academia Transforming multi-omics data into functional discoveries Addressing a potential USD 16 billion market VUGENE, a Lithuania-based multi-omics data analysis company, today announced the closing an investment round of €1 million, led by Superhero Capital together with participation from NGL Ventures, Coinvest Capital and angel investors. VUGENE will now deploy the new funds to accelerate its establishment as a global service-as-a-software company supporting researchers and industry customers worldwide by turning complex multi-omics data into functional […]
- [Returning Talent Creates Global Bioinformatics Innovations in Lithuania](https://vugene.com/returning-talent/): Innovation Agency Lithuania spoke to VUGENE team – Juozas Gordevičius, Gražina Mykolaitytė, Karolina Makovskytė – about their bold vision to create innovative biomedical data analysis solutions in collaboration with scientists in the US and Europe. In 2021 Juozas Gordevičius founded VUGENE, combining expertise in biology, data analysis, and programming. The team’s mission is to contribute to advancements in health-related scientific research. Located in Kaunas and Vilnius, VUGENE offers a wide range of biomedical data analysis services, including data quality control, statistical analysis, and the application of machine learning methods. These advanced solutions help detect new disease markers and address complex […]
- [Best Ways to Account for Batch Effects](https://vugene.com/best-ways-to-account-for-batch-effects/): What is a batch effects? With recent technological advancements, we’re generating high-throughput experimental data like never before. When this data comes from different experiments – with variations in timing, personnel, reagents, equipment, and platforms – non-biological factors, known as batch effects, can occur. These can create artificial differences, making it seem like there are biological differences between features of interest when, in fact, the variation is due to batch effects rather than true biological variation. How to proceed? Batch effects can be highly nonlinear, making it challenging to align datasets while preserving genuine biological variation. To ensure reliable and reproducible […]
- [Is scRNA-seq Always Superior to Bulk RNA-seq?](https://vugene.com/is-scrna-seq-always-superior-to-bulk-rna-seq/): Single-cell RNA sequencing (scRNA-seq) has transformed biological research by providing remarkable resolution for studying gene expression at the level of individual cells. This detailed view is invaluable for studying cellular diversity, identifying rare cell types, and understanding complex tissues like the brain or tumor microenvironments. However, does this mean scRNA-seq is always a better choice than bulk RNAseq? Not necessarily. Depth vs. breadth While scRNA-seq allows for sequencing a very high number of individual cells, it comes at the cost of reduced sequencing depth. In contrast, bulk RNA-seq enables deeper sequencing, providing a more comprehensive view of gene expression across […]
- [Multi-omics Data Analysis Approach Enables a Better Understanding of Scientific Problems](https://vugene.com/multi-omics-data-analysis-approach-enables-a-better-understanding-of-scientific-problems/): What is multi-omics? Through simultaneous analysis of different omics datasets – genomics, transcriptomics, proteomics, metabolomics, microbiomics, and epigenomics – multi-omics offers a comprehensive view of biological systems and potential for deep insights into the intricate interactions within living organisms. But how? While traditional single-omics approaches may offer valuable insights, they miss the complex network of interactions governing biological processes. With multi-omics this gap can be bridged through modeling of detailed relationships between molecular components. By assessing the flow of information from one omics level to another we can obtain a more complete understanding of health, disease, and physiology and ridge […]
- [Why Alternative Splicing Analysis Should Be a Part of Every RNAseq Experiment](https://vugene.com/why-alternative-splicing-analysis-should-be-a-part-of-every-rnaseq-experiment/): At VUGENE, we have integrated alternative splicing analysis into our RNA-seq pipeline and strongly recommend its use in every experiment as studying alternative splicing will significantly advance our understanding of mRNA complexity and regulation, providing valuable insights into disease etiology. The importance of alternative splicing The alternative removal of introns during mRNA maturation is essential for major biological processes in eukaryotes, such as cellular differentiation, response to environmental stress, and proper gene regulation. However, the ability to gain novel insights into the regulation and function of splicing is often hindered by the challenge of estimating transcript abundances from short-read RNA-seq […]
- [Detection of Differentially Methylated Regions Using Persimmon and Its Application to Study Epigenetic Changes in Zika Virus Infection](https://vugene.com/detection-of-differentially-methylated-regions-using-persimmon-and-its-application-to-study-epigenetic-changes-in-zika-virus-infection/): Background Zika virus is a mosquito-borne disease and its infection has no or mild symptoms in the majority of cases. However, Zika virus infection during pregnancy is associated with severe birth defects in newborns with microcephaly being the most concerning complication. The precise mechanisms of how the infection affects the fetus remain elusive even though the importance of epigenetic changes during Zika virus infection is known to be highly relevant. Inference of differentially methylated regions (DMRs) can provide useful insights in understanding the mechanisms of which genetic regions and how Zika virus infection affects in the fetus, yet the reliable […]
- [Stewart Graham, PhD](https://vugene.com/testimonial/): ”Working with VUGENE over the past few years has been an absolute pleasure. Their professionalism and timeliness are unmatched, but what really stands out is the statistical analysis and bioinformatic insight they provide. Their expertise has proven to be incredibly impactful to our research, and we couldn’t be more grateful for the valuable insights they have helped us uncover. Overall, I highly recommend VUGENE to anyone looking for a team of experts that truly goes above and beyond in their work”. Stewart Graham, PhD Director of Metabolomics Research, John and Marilyn Bishop Foundation Endowed Chair, Director of Alzheimer’s Disease Research, […]
- [Metabolomics Biomarkers of Neurodegeneration](https://vugene.com/metabolomics-biomarkers-of-neurodegeneration/): Client Corewell Health is a not-for-profit health system that provides health care and coverage with an exceptional team of 65,000+ dedicated people, including more than 12,000 physicians and advanced practice providers and more than 15,500 nurses providing care and services in 21 hospitals, 300+ outpatient locations and several post-acute facilities, and Priority Health, a provider-sponsored health plan serving more than 1.3 million members. Background Identify small molecules that could be used for diagnostics of various neurological conditions and neurodegenerative disorders. Solutions Targeted and untargeted mass spectrometry data processing pipeline Integration of metabolomics, epigenomics and other data sources AI-based predictors for […]
- [Learn How Automated Analysis and AI Modelling Helps Longevity Research](https://vugene.com/learn-how-automated-analysis-and-ai-modelling-helps-longevity-research/): Client The Clock Foundation is making epigenetic aging clocks more accessible for use with preclinical and clinical studies. This includes newer measures that help predict future healthspan and lifespan, such as PhenoAge and GrimAge, as well as epigenetic clocks for diverse mammalian species. Background Clinical studies of anti-aging interventions rely on epigenetic clocks that predict the biological age of a given sample. The client’s goal was to facilitate quick analysis of the most common experimental designs and to enable to shift focus on more complex studies as well as the development of novel epigenetic age predictors. We developed an automated […]
- [Maternal Oxytocin Treatment at Birth Increases Epigenetic Age in Male Offspring](https://vugene.com/maternal-oxytocin-treatment-at-birth-increases-epigenetic-age-in-male-offspring/): We are thrilled to announce a successful collaboration between VUGENE team – Juozas Gordevičius, Milda Milčiūtė, the Clock Foundation, and the University of Virginia, uncovering the long-lasting effects of exogenous oxytocin on infant development. Exogenous oxytocin, commonly used during labor, has been a topic of debate regarding its influence on offspring development. This study, centered on prairie voles (Microtus ochrogaster), sheds light on the complex interplay between perinatal oxytocin exposure and its potential epigenetic and transcriptomic outcomes. The study revealed that oxytocin exposure during birth led to increased epigenetic age in the exposed animals compared to the control group that […]

## Pages

- [DEMO](https://vugene.com/demo/): Schedule a demo review with our team Discover how we can empower your research with advanced data analysis solutions. Featured demo projects: Multi-omics analysis Proteomics analysis Gene expression analysis Transcriptomics analysis Metabolomics analysis Epigenetics analysis We believe every breakthrough begins with a conversation – let’s start yours today!
- [TERMS OF USE](https://vugene.com/legal/terms-of-use/):   Back Terms of use Rules that govern use of VUGENE’s online services Effective: July 15, 2025 1. Scope of the Terms of Use 1.1. These Terms of Use (hereinafter – the “Terms”) set rules and conditions on which persons (hereinafter – “Clients”, “Client”, “you”) are entitled to access and use consulting services in the field of bioinformatic and computational biological research, analysis, interpretation of data (the Services), provided by us – VUGENE UAB or VUGENE LLC (dependent on territory where the Services are used as explained hereinafter) (hereinafter – “VUGENE”, “we” and “us”) online at vugene.com (the “Platform”). 1.2. […]
- [Legal documents](https://vugene.com/legal/): Legal documents Privacy Policy This GDPR-compliant privacy policy discloses how VUGENE collects and uses the personal data and other information. Terms of Use The terms of use outlines the rules and restrictions that govern your use of VUGENE’s products, services, and applications.
- [EU GRANT InoPažanga](https://vugene.com/eu-grant-inopazanga/): Back An automated platform for the identification and data analysis of single-cell DNA modifications based on computational and artificial intelligence methods (NR. 02-019-K-0002) Project coordinator VUGENE Project description VUGENE aims to develop an innovative genetic testing data analysis platform powered by artificial intelligence and cloud computing technologies. This tool will enable the analysis of genetic data to be up to ten times faster and simpler, empowering genetic testing laboratories, life science research organizations, and drug discovery companies to conduct a wide range of genetic tests more quickly, cost-effectively, and accurately. This advancement is expected to lead to breakthroughs in disease […]
- [EU GRANT Oncointegra](https://vugene.com/eu-grant-oncointegra/): Back Implementation of mission-driven science and innovation programmes (NR. 02-002-P-0001) Project coordinator Innovation Agency Project partners Kaunas University of Technology consortium (Vilnius Gediminas Technical University, Mykolas Romeris University, Association Infobalt, Devslate Group, Novian pro, Lithuanian Cybercrime Competence and Research Centre, Transcendent Group Baltics, Getweb, Acrux cyber services, NRD CS, Baltic Institute of Advanced Technologies). Vilnius Gediminas Technical University Consortium (Vilnius Gediminas Technical University, Kaunas University of Technology, Lithuanian Confederation of Industrialists, Lithuanian Innovation Centre, Saulėtekis Valley Science and Technology Park, Kaunas Science and Technology Park, SG dujos Auto, Arginta, 3D Creative, Ekobaze, Provectus Redivivus, Kelių priežiūra, Soli Tek R&D, Nanoversa). […]
- [CONTACT](https://vugene.com/contact/): Let’s start your project together – contact us now VUGENE, LLC  PMB 96578Suite 301, 625 Kenmoor Avenue SoutheastGrand Rapids, MI 49546, USA VUGENE, UAB Antakalnio st. 17, 12th buildingLT-10312 Vilnius, Lithuania K. Donelaičio st. 62 – 214 LT-44248 Kaunas, Lithuania General inquiries Email us at hi@vugene.com Book a meeting Schedule a call Schedule a call Get in touch
- [EU GRANTS](https://vugene.com/grants/): EU Grants VUGENE is proud to be involved in projects funded by the European Union that aim to stimulate innovation and promote progress Ongoing Implementation of mission-driven science and innovation programmes (NR. 02-002-P-0001) 2023 – 2026 An automated platform for the identification and data analysis of single-cell DNA modifications based on computational and artificial intelligence methods (NR. 02-019-K-0002) 2024 – 2026 Let’s start your project together – contact us now Please describe your research problem and we will get back to you to get things moving forward! TRUSTED BY
- [ABOUT](https://vugene.com/about/): About VUGENE VUGENE is a Service-as-a-Software company committed to ensuring that customers benefit from its services and achieve their target results VUGENE was founded by Juozas Gordevičius with the core mission to bring together experts in biology, data analysis, and programming to transform and advance health-related scientific research. Our value lies in transforming multi-omics data into functional discoveries – saving time, reducing complexity and empowering better-informed decisions through continuous communication and data exploration. We tell stories with omics data Embrace the power of machine learning and artificial intelligence with our ML/AI services. From predictive modeling to pattern recognition, we leverage […]
- [SOLUTIONS](https://vugene.com/solutions/): Reach your research goals faster We excel at reproducible, automated and cutting-edge analysis and interpretation of biomedical research data Statistics & interpretation Our automated workflows are built to handle complex experimental designs, apply advanced statistical models, and help interpret your findings with pathway searches across a multitude of databases. You will get a clear description of methods, publication-ready figures, and straightforward result summaries to advance your research. Machine learning & artificial intelligence We train and evaluate predictive models tailored to your data, using both classical machine learning techniques and cutting-edge deep learning methods. From feature selection to model optimization, we […]
- [PRIVACY POLICY](https://vugene.com/legal/legal-privacy-policy/): Back Privacy policy Effective: December 01, 2024   VUGENE, UAB (hereinafter the “Institution”) (legal entity code 305968370, registered address K. Donelaičio str. 62-1, Kaunas, Lithuania) is your data controller and is responsible for the protection of your personal information that you disclose to the Institution. VUGENE, UAB carries out the processing of personal data in accordance with Regulation No. 2016/679 of the European Parliament and of the Council (General Data Protection Regulation) and the rules of personal data processing in the Institution approved by the Chief Executive Director of the VUGENE, UAB and other legal acts of the Republic of […]
- [RESOURCES](https://vugene.com/resources/)
- [ANALYSIS](https://vugene.com/analysis/): Telling stories with omics data VUGENE is a biomedical data science company specialising in delivering top-level analysis and interpretation, that drive future innovations Genomics Our genomics data analysis extracts insights from DNA sequences by identifying and interpreting SNVs, insertions, deletions, and structural variants. Applied to population genetics, rare diseases, and cancer genomics, our analysis aids in developing precise treatments tailored to individual genetic profiles. right Learn more Transcriptomics Our RNA-seq data analysis workflows provide quantification of gene expression, alternative splicing, and other transcribed elements. We tailor statistical analysis to identify differentially expressed elements within even the most complex experimental designs. […]
- [VUGENE - Biomedical data science company](https://vugene.com/): Move forward with data analysis results Forget delays and vague reports VUGENE multi-omics platform can boost your productivity and innovation by transforming your discovery process! Get in touch Request a Demo Move forward with data analysis results Forget delays and vague reports VUGENE multi-omics platform can boost your productivity and innovation by transforming your discovery process! Get in touch Request a Demo Move forward with data analysis results Forget delays and vague reports VUGENE multi-omics platform can boost your productivity and innovation by transforming your discovery process! Get in touch Request a Demo TRUSTED BY VUGENE multi-omics platform Learn how […]


[comment]: # (Generated by Hostinger Tools Plugin)